PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Change in Other Operating Liabilities (2012 - 2023)

Updated

Analysis

PharmaCyte Biotech (PMCB) Change in Other Operating Liabilities (2012 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -112.00 Mn
10 PharmaCyte Biotech 3.76 Mn -69.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2023 1.45 Mn
Jul 31, 2013 7,902.00
Apr 30, 2013 11,267.00
Jan 31, 2013 10,775.00
Oct 31, 2012 9,515.00
Jul 31, 2012 9,241.00
API Access

PharmaCyte Biotech Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEY